{"product_id":"detriflow-tablets-2mg-1-strip-14-tablets","title":"Detriflow Tablets 2Mg (1 Strip = 14 Tablets)","description":"\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003eDetriflow Tablets\u003cspan\u003e \u003c\/span\u003eSpecification\u003c\/h1\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eRequires Prescription (YES\/NO)\u003c\/h1\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eGenerics\u003c\/h1\u003e\n\u003cp\u003eTolterodine-L Tartrate\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eUsed For\u003c\/h1\u003e\n\u003cp\u003eUrinary Incontinence\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eHow it works\u003c\/h1\u003e\n\u003cp\u003eTolterodine acts as a competitive antagonist of acetylcholine at postganglionic muscarinic receptors. Both urinary bladder contraction and salivation are mediated via cholinergic muscarinic receptors. After oral administration, tolterodine is metabolized in the liver, resulting in the formation of 5-hydroxymethyl tolterodine (5-HMT), the major pharmacologically active metabolite. 5-HMT, which exhibits an antimuscarinic activity similar to that of tolterodine, contributes significantly to the therapeutic effect. Both tolterodine and 5-HMT exhibit a high specificity for muscarinic receptors, since both show negligible activity or affinity for other neurotransmitter receptors and other potential cellular targets, such as calcium channels.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003eDetriflow Tablets\u003cspan\u003e \u003c\/span\u003eUsage And Safety\u003c\/h1\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eDosage\u003c\/h1\u003e\n\u003cp\u003eTolterodine-L Tartrate\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eSide Effects\u003c\/h1\u003e\n\u003cp\u003eDry mouth , Headache , Constipation , Stomach pain .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eDrug Interactions\u003c\/h1\u003e\n\u003cp\u003ePotent CYP2D6 Inhibitors e.g. Fluoxetine , Potent CYP3A4 Inhibitors e.g. Ketoconazole , itraconazole, clarithromycin, or ritonavir .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eIndication\u003c\/h1\u003e\n\u003cp\u003eIt is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eWhen not to Use\u003c\/h1\u003e\n\u003cp\u003eIt is contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma.It is also contraindicated in patients with known hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like Tolterodine Tartrate, are metabolized to 5-hydroxymethyl tolterodine .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003eDetriflow Tablets\u003cspan\u003e \u003c\/span\u003ePrecautions\u003c\/h1\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003ePrecaution\u003c\/h1\u003e\n\u003cp\u003eAnaphylaxis and angioedema requiring hospitalization and emergency medical treatment have occurred with the first or subsequent doses of Tolterodine Tartrate. In the event of difficulty in breathing, upper airway obstruction, or fall in blood pressure, it should be discontinued and appropriate therapy promptly provided.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003eDetriflow Tablets\u003cspan\u003e \u003c\/span\u003eWarnings\u003c\/h1\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eWarning 1\u003c\/h1\u003e\n\u003cp\u003eAdminister Tolterodine Tartrate with caution to patients with clinically significant bladder outflow obstruction because of the risk of urinary retention .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eWarning 2\u003c\/h1\u003e\n\u003cp\u003eAdminister Tolterodine Tartrate with caution in patients with gastrointestinal obstructive disorders because of the risk of gastric retention. Tolterodine Tartrate , like other antimuscarinic drugs, may decrease gastrointestinal motility and should be used with caution in patients with conditions associated with decreased gastrointestinal motility (e.g., intestinal atony) .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eWarning 3\u003c\/h1\u003e\n\u003cp\u003eTolterodine Tartrate is associated with anticholinergic central nervous system (CNS) effects including dizziness and somnolence . Patients should be monitored for signs of anticholinergic CNS effects, particularly after beginning treatment or increasing the dose. Advise patients not to drive or operate heavy machinery until the drug's effects have been determined. If a patient experiences anticholinergic CNS effects, dose reduction or drug discontinuation should be considered.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003eDetriflow Tablets\u003cspan\u003e \u003c\/span\u003eAdditional Information\u003c\/h1\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003ePregnancy category\u003c\/h1\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003ch1 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003eStorage (YES\/NO)\u003c\/h1\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Taabib.com","offers":[{"title":"Default Title","offer_id":50094525120788,"sku":null,"price":652.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0759\/3364\/7124\/files\/detriflow_2mg_2.jpg?v=1738933810","url":"https:\/\/www.taabib.com\/products\/detriflow-tablets-2mg-1-strip-14-tablets","provider":"Taabib.com","version":"1.0","type":"link"}